March 25, 2019
Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research
Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 25, 2019
Axcella Appoints Shreeram Aradhye, M.B.B.S., M.D., as Executive Vice President, Chief Development Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…
March 23, 2019
City of Hope Study Finds Popular Diabetes Diagnosis Test Misses Most Cases
The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…
March 22, 2019
Gossamer Bio Announces 2018 Annual Financial Results
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the…
March 22, 2019
Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox)…
March 22, 2019
Alcohol Addiction – Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Alcohol Addiction – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
March 22, 2019
Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent
BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau’s…
March 22, 2019
$69+ Billion Diabetes Therapies Market by 2023: Opportunities & Strategies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetes Therapies Global Market Opportunities And Strategies To 2023” report has been added to ResearchAndMarkets.com’s offering. This report…
March 22, 2019
Neurotrope jumps in the Alzheimer’s solution chase, amid Biogen’s, Eisai’s dropping aducanunab trial
Neurotrope said Friday, commenting Biogen Inc.’s decision to discontinue its global Phase 3 trials of aducanunab in Alzheimer’s disease, Phase 2 clinical trial using its drug Bryostatin during the second half of 2019.
March 22, 2019
Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer ST.…